Determinants of human and mouse melanoma cell sensitivities to oleandrin

Journal of Experimental Therapeutics and Oncology

Volumn 7, Issue 3, 2008, Pages 195-205

  Lin, Yun ^a   Dubinsky, William P ^b   Ho, Dah H ^c   Felix, Edward ^c   Newman, Robert A ^c  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Cardiac glycosides; Drug uptake; Isoform; K+ ATPase; Na+; Oleandrin; Ouabain

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ANVIRZEL; CARDIAC GLYCOSIDE; ISOENZYME; NERIUM OLEANDER EXTRACT; OLEANDRIN; OUABAIN; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG SENSITIVITY; DRUG UPTAKE; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MELANOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CARDENOLIDES; CARDIAC GLYCOSIDES; CELL PROLIFERATION; ENZYME INHIBITORS; HUMANS; MELANOMA, EXPERIMENTAL; MICE; OUABAIN; PROTEIN ISOFORMS; SODIUM-POTASSIUM-EXCHANGING ATPASE; TUMOR CELLS, CULTURED;

EID: 56749177506     PISSN: 13594117     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Newman RA, Cisneros A, Felix E, Vijjeswarapu M, Lin Y, Yang P, Azadi P. Comparison and preliminary pharmacology studies with Anvirzel: An extract of Neruium oleander. J. Herbal Pharmacotherapy 1:1-14, 2001.
2. Hung KC. The pharmacology of Chinese herbs. Boca Raton, FL: CRC Press, 1999:53.
3. Stenkvist B, Pengtsson E, Dahlqvist B, Eriksson O, Jerkrans T, Nordin B. Cardiac glycosides and breast cancer revisited (Letter). New Engl. J. Med. 306(8): 484, 1982.
4. Stevkvist B. Is digitalis a therapy for breast carcinoma. Oncol. Rep. 6: 493-496, 1999.
5. Mekhali T, Kellackey C, Hutson T, Olencki GT, Budd GT, Peereboom R, Dreicer P, Elson R, Ganapathi R, Bukowski R. Phase I study of Anvirzel ™ in patients with advanced solid tumors. Proc. Amer. Soc. Clin. Oncol. 20:826, 2001.
6. McConkey DJ, Lin Y, Nutt LK, Ozel HZ, Newman RA. Cardiac glycosides stimulate Ca++ increases and apoptosis in androgen independent metastatic human prostate adenocarcinoma cells. Cancer Res. 60: 3807-3812, 2001.
7. Manna SK, Sah NK, Newman RA, Cisneros A, Aggarwal BB. Oleandrin suppresses activation of nuclear transcription factor κB, activator protein-1, and c-Jun NH2-terminal kinase. Cancer Res.60:3838- 47, 2000.
8. +-ATPase via activation of ERK1/2 Map kinases in human renal tubular cells. Cell. Mol. Life Sci. 62: 2782-90, 2004.
9. Valente RC, Capella LS, Monteiro RQ, Rumjanek VM, Lopes AG, Capella MAM. Mechanisms of ouabain toxicity. FASEB Journal 17: 1700-02, 2003.
10. Newman RA, Yang P, Hittelman WN, Tao L, Ho DH. Oleandrin-mediated oxidative stress in human melanoma cells. J.Exptal Therap & Oncol. 5: 167-181, 2006.
11. Smith JA, Madden T, Vijjeswarapu M, Newman RA. Inhibition of export of fibroblast growth factor-2 (FGF-2) from the prostate cancer cell lines PC3 and DU145 by Anvirzel and its cardiac glycoside component, oleandrin. Biochem. Pharmacol. 62: 469-472, 2001.
12. Pathak S, Multani AS, Narayan S, Kumar V, Newman, RA. Anvirzel™, an extract of Nerium oleander, induces cell death in human but not murine cancer cells. Anti-cancer Drugs 11: 455-463, 2000.
13. Gupta R, Chopra A, Stetsko DK. Cellular basis for the species differences in sensitivity to cardiac glycosides (Digitalis). J. cell. Physiol. 127: 197-206, 1986.
14. +,-ATPase by oleandrin and oleandrigenin, and their detection by digoxin immunoassay. Clin. Chem. 42: 1654-58, 1996.
15. +, - ATPase isozyme diversity; comparative biochemistry and physiological implications of novel functional interactions. Biosci. Rep. 20 (2): 51-91, 2000.
16. Nagano K, Kawakami K, Na,K-ATPase - its structure, gene isoforms, and possible roles in cardiac cells. Nippoon Rinsho 51 (5) 1496-503, 1993.
17. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytoto xicity assays. J. Immunol Methods 65(1-2): 55-63, 1983.
18. Wang X, Plomley JB, Newman RA, Cisneros A. LC/MS/MS analyses of an oleander extract for cancer treatment. Anal Chem 72(15):3547-52, 2000.
19. Costantin J, Alcalen S, de Souza Otero A, Dubinsky WP, Schultz SG. Reconstitution of an inwardly rectifying potassium channel from the basolateral membranes of Necturus enterocytes into planar lipid bilayers. Proc Natl Acad Sci USA 86(13):5212-6, 1989.
20. Dubinsky WP, Mayorga-Wark O, Schultz SG. Colocalization of glycolytic enzyme activity and KATP channels in basolateral membrane of Necturus enterocytes. Am J Physiol 275(6 Pt 1):C1653-9, 1998.
21. 2+ exchanger protein levels in human heart failure. Circulation 99(16):2105-12, 1999.
22. Peng L, Arystarkhova E, Sweadner KJ. Plasticity of Na,K-ATPase isoform expression in cultures of flat astrocytes: species differences in gene expression. Glia 1998;24(3):257-71.
23. Tao QF, Hollenberg NK, Graves SW. Sodium pump inhibition and regional expression of sodium pump alpha-isoforms in lens. Hypertension 34(5):1168-74, 1999.
24. Growth inhibitory effect of cardiac glycosides and aglycones on neoplastic cells: in vitro and in vivo studies, Gann 58: 521-528, 1967.
25. Gupta RS, Chopra A, Stetsko R. Cellular basis for the species differences in sensitivity to cardiac glycosides (digitalis). J. cellular Physiol. 127(2): 197-206, 1986.
26. Haux J. Lam Digitoxin is a potential anticancer agent for several types of cancer. Med Hypotheses. Dec;53(6):543-8, 1999.
27. Stenkvist B, Bengtsson E, Eklund G, Eriksson O, Holmquist J, Nordin B, Westman-Naeser S. Evidence of a modifying influence of heart glucosides on the development of breast cancer. Analy. Quan. Cytolo. 2(1) 49-54, 1980.
28. Mekhail T, Kellackey C, Hutson T, Olencki T, Budd GT, Peereboom D, Dreicer R, Elson P, Ganapathi R, Bukowski, R. Phase I study of Anvirzel™ in patients with advanced solid tumors. Proc. Am. Soc. Clin. Oncol. #2077, 2001.
29. Ramirez-Ortega M, Maldonado-Lagunas V, Melendez-Zajgla J, Carrillo-Hernandez JF, Pastelin-Hernandez G, Picazo-Picazo O, Ceballos-Reyes G. Proliferation and apoptosis of HeLa cells induced by in vitro stimulation with digitalis. Eur J Pharmacol. 18;534(1-3):71-6. 2006.
30. Oweis S, Wu L, Kiela PR, Zhao H, Malhotra D, Ghishan FK, Xie Z, Shapiro JI, Liu J. Cardiac glycoside down regulates NHE3 activity and expression in LLC-PK1 cells. Am J Physiol Renal Physiol. 290(5):F995-6, 2006.
31. Yang Q, Huang W, Jozwik C, Lin Y, Glasman M, Caohuy H, Srivastava M, Esposito D, Gillette W, Hartley J, Pollard HB. Cardiac glycosides inhibit TNF-alpha/NF-kappaB signaling by blocking recruitment of TNF receptor-associated death domain to the TNF receptor. Proc Natl Acad Sci U S A. 5;102(27):9631-6, 2005.
32. +-ATPase digitalis binding site. J Mol Graph Model. 23(6):465-75, 2005.
33. Blanco G, Sanchez G, Melton RJ, Tourtellotte WG, Mercer RW. The alpha4 isoform of the Na,K-ATPase is expressed in the germ cells of the testes. J Histochem Cytochem 48(8):1023-32, 2000.
34. +-ATPase alpha-subunit gene is expressed in testis. Proc Natl Acad Sci U S A 91(26):12952-6, 1994.
35. Lingrel JB, Orlowski J, Shull MM, Price EM. Molecular genetics of Na,K-ATPase. Prog Nucleic Acid Res Mol Biol 38:37-89, 1990.
36. +-ATPase catalytic subunit. Proc Natl Acad Sci U S A 84(12):4039-43, 1987.
37. Crambert G, Hasler U, Beggah AT, Yu C, Modyanov NN, Horisberger JD, Lelievre L, Geering K. Transport and pharmacological properties of nine different human Na, K-ATPase isozymes. J Biol Chem 275(3):1976-86, 2000.
38. Blanco G, Mercer RW. Isozymes of the Na-K-ATPase: heterogeneity in structure, diversity in function. Am J Physiol 275(5, Pt 2):F633-50, 1998.
39. +)-ATPase preparations from different tissues and species. Determination of kinetic constants and dissociation constants. Biochim Biophys Acta 307(2):386-98, 1973.
40. +-ATPase. Biochim Biophys Acta 988(2): 185-220, 1989.
41. Jewell EA, Lingrel JB. Comparison of the substrate dependence properties of the rat Na,K-ATPase alpha 1, alpha 2, and alpha 3 isoforms expressed in HeLa cells. J Biol Chem 266(25):16925-30, 1991.
42. Blanco G, Sanchez G, Mercer RW. Comparison of the enzymatic properties of the Na,K-ATPase alpha 3 beta 1 and alpha 3 beta 2 isozymes. Biochemistry 34(31):9897-903, 1995.
43. O'Brien WJ, Lingrel JB, Wallick ET. Ouabain binding kinetics of the rat alpha two and alpha three isoforms of the sodium-potassium adenosine triphosphate Arch Biochem Biophys. 310(1):32-9, 1994.
44. Akera T, Ng YC, Hadley R, Katano Y, Brody TM. High affinity and low affinity ouabain binding sites in the rat heart. Eur J Pharmacol 132(2-3):137-46, 1986.
45. Erdmann E. Changes of affinity and capacity of cardiac glycoside receptors. Arzneimittelforschung 35(12A):1948-52, 1985.